CKR-334

N/A

Report date: 2023/08/04 13:44:09
NME

Base Information

Drug NameCKR-334
Drug Alias NameCKR-334
ClassificationSmall molecules
Mechanisms of ActionCXXC5 protein inhibitorsWnt signalling pathway modulators
TargetsCXXC-type zinc finger protein 5
Therapy Area/IndicationsObesityDiabetes MellitusMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCK Regeon Inc
China Registration ClassN/A

Develop Information

Active CompaniesCK Regeon Inc
Inactive CompaniesN/A
Active IndicationsObesityDiabetes MellitusMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A